RUZURGI

Identification of Ruzurgi:

No description

Search images on Google      Product Monograph

Active Ingredients:

DIN: 02503034

Dosage Form(s): TABLET

Route(s) of Administration: ORAL

Description: IN ACCORDANCE WITH THE FCA DECISION IN A-78-22, THE 2021-06-24 DECISION (DATA PROTECTION) WAS RESTORED, AND A NEW NOC WAS ISSUED.

Schedule: Prescription

Company: MEDUNIK CANADA

ATC:

 

External Links for Ruzurgi:

Search on Google